The debate highlighted tau prion-like transmission but did not resolve how different tau conformations compete and which structural features determine propagation efficiency. Understanding these determinants is critical for predicting disease progression patterns.
Source: Debate session sess_SDA-2026-04-02-gap-tau-propagation-20260402 (Analysis: SDA-2026-04-02-gap-tau-propagation-20260402)
TREM2 on microglia normally clears tau pathology, but sTREM2 signaling mediates early synaptic injury and may paradoxically facilitate strain selection. Microglia that fail to completely degrade captured tau strains may repackage conformationally altered tau into exosomes.
Interactive 3D viewer powered by RCSB PDB / Mol*. Use mouse to rotate, scroll to zoom.
Dimension Scores
How to read this chart:
Each hypothesis is scored across 10 dimensions that determine scientific merit and therapeutic potential.
The blue labels show high-weight dimensions (mechanistic plausibility, evidence strength),
green shows moderate-weight factors (safety, competition), and
yellow shows supporting dimensions (data availability, reproducibility).
Percentage weights indicate relative importance in the composite score.
10 citations10 with PMIDValidation: 0%5 supporting / 5 opposing
Evidence Matrix — sortable by strength/year, click Abstract to expand
Claim
Type
Source
Strength ↕
Year ↕
Quality ↕
PMIDs
Abstract
sTREM2 mediates early synaptic injury in AD indepe…
Multi-persona evaluation:
This hypothesis was debated by AI agents with complementary expertise.
The Theorist explores mechanisms,
the Skeptic challenges assumptions,
the Domain Expert assesses real-world feasibility, and
the Synthesizer produces final scores.
Expand each card to see their arguments.
Gap Analysis | 4 rounds | 2026-04-15 | View Analysis
🧬TheoristProposes novel mechanisms and generates creative hypotheses▼
Novel Therapeutic Hypotheses: Molecular Determinants of Tau Strain Selection
Description: The low-density lipoprotein receptor-related protein 1 (LRP1) acts as a strain-selective gateway for tau internalization. Certain tau conformations expose binding motifs that preferentially engage LRP1's cluster II ligand-binding repeats, enabling faster neuronal uptake and more efficient trans-synaptic spread. Blocking LRP1-tau interaction selectively reduces uptake of high-propagation strains.
Target: LRP
🔍SkepticIdentifies weaknesses, alternative explanations, and methodological concerns▼
Critical Evaluation of Tau Strain Selection Hypotheses
The central premise—that tau strains expose distinct LRP1-binding motifs enabling "strain-selective" internalization—lacks direct experimental validation. While LRP1 mediates bulk tau uptake, the evidence that it discriminates between conformational variants is correlative. LRP1 is a highly promiscuous receptor with overlapping ligand specificity across the LDLR family, making specific strain recognition unlikely to be the primary determinant of propagati
🎯Domain ExpertAssesses practical feasibility, druggability, and clinical translation▼
Drug Discovery Analysis: Tau Strain Selection Hypotheses
Executive Assessment
Of the seven hypotheses, two targets—OGT and LRP1—have sufficient chemical matter, mechanistic plausibility, and druggability profiles to justify near-term therapeutic investigation. The remaining hypotheses either lack viable chemical starting points, require fundamental biology validation, or target mechanisms with questionable selectivity. Below I evaluate each hypothesis through the lens of practical drug development.